Document is current
Any future updates will be listed below
-
Authors
Conway, Olivia J
Carrasquillo, Minerva M
Wang, Xue
Bredenberg, Jenny M
Reddy, Joseph S
Strickland, Samantha L
Younkin, Curtis S
Burgess, Jeremy D
Allen, Mariet
Lincoln, Sarah J
Nguyen, Thuy
Malphrus, Kimberly G
Soto, Alexandra I
Walton, Ronald L
Boeve, Bradley F
Petersen, Ronald C
Lucas, John A
Ferman, Tanis J
Cheshire, William P
van Gerpen, Jay A
Uitti, Ryan J
Wszolek, Zbigniew K
Ross, Owen A
Dickson, Dennis W
Graff-Radford, Neill R
Ertekin-Taner, Nilüfer https://orcid.org/0000-0003-4436-8889
-
Funding
Funding for this research was provided by:
National Institute on Aging (RF AG051504, U01 AG046139)
National Institute of Neurological Disorders and Stroke (R01 NS080820, R01 NS078086)
- License Information
-
More Information
Article History
Received: 24 August 2018
Accepted: 4 October 2018
First Online: 11 October 2018
Ethics approval and consent to participate
: The Mayo Clinic Institutional Review Board (IRB) approved all procedures for this study and we followed all appropriate protocols.
: All participants were properly consented for this study.
: RCP consults for Roche, Inc., Merck, Inc., Genentech, Inc., and Biogen, Inc., GE Healthcare, and receives royalties from Oxford University Press for the publication of Mild Cognitive Impairment. NRG-R has served on the editorial board of Alzheimer Disease and Therapy; has received publishing royalties from UpToDate; and has received research support from TauRx, Lilly, Biogen, and NIA. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
